Catheter Precision

VTAK

Market cap $2.77M

Company Deploys Scalable Short-Haul Model into Peak Travel Window as Millions Exit NYC Metro Flagship Routes to Nantucket, Hamptons, and Martha's Vineyard Positioned for Immediate Revenue Acceleration and High Utilization FORT MILL, S.C., May 21, 2026 (GLOBE NEWSWIRE) -- Flyte, a regional air mobility company focused on making private aviation more accessible and flexible for modern travelers, today announced the full-scale activation of its Memorial Day flight network, aggressively deploying aircraft across its Northeast corridor to capitalize on one of the largest and most predictable travel surges of the year.

Company Deploys Scalable Short-Haul Model Following Kentucky Derby to Monetize Peak Travel Window Flagship Routes from NYC, Boston, DC, and Philadelphia Positioned to Drive Immediate Revenue, High Utilization, and Dense Flight Activity NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”), today announced the positioning of aircraft across the Northeast to support increased travel demand this coming weekend in anticipation of the Preakness Stakes on Saturday, May 16th. The program centers on Baltimore/Washington International Airport (BWI), the primary access point for race attendees, with high-frequency short-haul service from major Northeast metros.

Premium Short-Haul Operator Continues Planned Vision Jet Fleet Expansion and Opens Hiring Pipeline for Impacted Pilots and Aviation Professionals Premium Short-Haul Operator Continues Planned Vision Jet Fleet Expansion and Opens Hiring Pipeline for Impacted Pilots and Aviation Professionals

Positioned to Meet Accelerating Travel Activity across New York City, The Hamptons, Nantucket and Martha's Vineyard Scalable Short-Haul Luxury Aviation Platform Targeting Key Regional Travel Markets FORT MILL, S.C., April 28, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”), today announced the expansion of its Cirrus Vision Jet fleet ahead of peak summer demand, scaling short-haul service from New York City to East Hampton, Nantucket, Martha's Vineyard, Newport, and Cape Cod.

Major Carriers Accelerate Route Cuts as Economics Break Down, Creating Multi-Billion-Dollar Opportunity in Regional Air Mobility Flyte Expands Focus on High-Frequency Short-Haul Routes to Capture Surging Demand as Industry Economics Continue to Shift FORT MILL, S.C., April 20, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE American: VTAK), today announced it is accelerating expansion in short-haul markets as major global airlines rapidly retreat from regional routes amid rising fuel costs, operational constraints, and shifting route economics.

FORT MILL, S.C., April 06, 2026 (GLOBE NEWSWIRE) --  Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that the manuscript titled “Safety and Efficacy of LockeT Suture Retention Device for Large-Bore Venous Access Closure” has been accepted by the Journal of Interventional Cardiac Electrophysiology (JICE), a leading medical journal in the field of electrophysiology.

Clinical, Commercial and Regulatory Milestones Achieved in 2025 Establish a Strong Foundation in Life Sciences as Revenue Increases 95% Year Over Year

Transaction Delivers Wholly Owned, Scalable Asset-Backed, Aviation Platform with Accelerating Revenue and Consolidated Control Positions VTAK at the Center of High-Growth Regional Air Mobility Ahead of Industry-Wide eVTOL Commercialization FORT MILL, S.C., March 10, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) today announced that it has completed the acquisition of the remaining 80.02% equity interest in Fly Flyte, Inc. (“Flyte”) from Creatd, Inc. (OTCQB: CRTDD), resulting in 100% ownership of the AI-enabled regional aviation operator.

FORT MILL, S.C., March 06, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a pioneer in medical technology for the cardiac electrophysiology market, today announced that its LockeT suture retention device will be highlighted during live procedural cases at the International Symposium of Left Atrial Appendage 2026 conference. The event, co-hosted by the Academy for Continued Healthcare Learning (ACHL) and ISLAA Foundation, will take place from March 5-6, 2026, at the Biltmore Hotel in Los Angeles, California.

Catheter Precision (NYSE: VTAK) shares are down on Thursday as the company announced a strategic divestiture of its non-core assets.